Rigel Pharmaceuticals, Inc.【RIGL】 純利益の推移

機能の使い方
(単位:千ドル) 純利益 前年比(%)
4Q25 268,065 +1769.2%
3Q25 27,900 +124.6%
2Q25 59,613 -5887.7%
1Q25 11,446 -238.8%
4Q24 14,341 +1845.9%
3Q24 12,421 -318.2%
2Q24 -1,030 -84.4%
1Q24 -8,247 -39.1%
4Q23 737 -47.4%
3Q23 -5,692 -70.1%
2Q23 -6,600 -51.1%
1Q23 -13,536 -50.7%
4Q22 1,401 -106.2%
3Q22 -19,037 -9.1%
2Q22 -13,492 -2.4%
1Q22 -27,445 -169.5%
4Q21 -22,641 +17.7%
3Q21 -20,952 +47.8%
2Q21 -13,821 -21.4%
1Q21 39,500 +85.9%
4Q20 -19,237 +11.8%
3Q20 -14,174 +23.4%
2Q20 -17,576 -14.7%
1Q20 21,243 -220.7%
4Q19 -17,200 -632.8%
3Q19 -11,490 -51.7%
2Q19 -20,606 -19.4%
1Q19 -17,598 -27.8%
4Q18 3,228 -112.5%
3Q18 -23,766 +34.6%
2Q18 -25,557 -
1Q18 -24,385 -
4Q17 -25,871 -
3Q17 -17,660 -
2Q11 -21,474 -